• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水溶性低影响安帕金前药CX1942及其活性部分CX1763的临床前特征研究

Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763.

作者信息

Radin Daniel P, Zhong Sheng, Cerne Rok, Shoaib Mohammed, Witkin Jeffrey M, Lippa Arnold

机构信息

RespireRx Pharmaceuticals Inc., 126 Valley Road, Glen Rock, NJ 07452, USA.

Psychogenics, 215 College Road, Paramus, NJ 07652, USA.

出版信息

Future Med Chem. 2024;16(22):2325-2336. doi: 10.1080/17568919.2024.2401312. Epub 2024 Sep 20.

DOI:10.1080/17568919.2024.2401312
PMID:39301929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11622767/
Abstract

AMPA-glutamate receptor (AMPAR) dysfunction mediates multiple neurological/neuropsychiatric disorders. Ampakines bind AMPARs and allosterically enhance glutamate-elicited currents. This report describes the activity of the water-soluble ampakine CX1942 prodrug and the active moiety CX1763. CX1763 and CX1942 enhance synaptic transmission in hippocampi of rats. CX1763 increases attention in the 5CSRTT in rats and reduces amphetamine-induced hyperactivity in mice. CX1942 potently reverses opioid-induced respiratory depression in rats. CX1942/CX1763 was effective at 2.5-10 mg/kg. CX1763 lacked epileptogenicity up to 1500 mg/kg in rats. These data document that CX1942 and CX1763 are active and without prominent side effects in multiple pre-clinical assays. CX1942 could serve as a prodrug for CX1763 with the advantage of high water solubility as in an intravenous formulation.

摘要

α-氨基-3-羟基-5-甲基-4-异恶唑丙酸型谷氨酸受体(AMPA受体)功能障碍介导多种神经/神经精神疾病。安帕金与AMPA受体结合并变构增强谷氨酸引发的电流。本报告描述了水溶性安帕金CX1942前药和活性部分CX1763的活性。CX1763和CX1942增强大鼠海马体中的突触传递。CX1763提高大鼠在5选串行反应时任务中的注意力,并减少小鼠中苯丙胺诱导的多动。CX1942有效逆转大鼠中阿片类药物诱导的呼吸抑制。CX1942/CX1763在2.5-10mg/kg时有效。在大鼠中,高达1500mg/kg的CX1763没有致癫痫性。这些数据证明CX1942和CX1763具有活性,并且在多种临床前试验中没有明显副作用。CX1942可以作为CX1763的前药,具有高水溶性的优点,如在静脉制剂中。

相似文献

1
Preclinical characterization of a water-soluble low-impact ampakine prodrug, CX1942 and its active moiety, CX1763.水溶性低影响安帕金前药CX1942及其活性部分CX1763的临床前特征研究
Future Med Chem. 2024;16(22):2325-2336. doi: 10.1080/17568919.2024.2401312. Epub 2024 Sep 20.
2
Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjects.低影响性安帕金CX717在年轻健康男性受试者以及老年健康男性和女性受试者中的安全性、耐受性和药代动力学特征。
Eur J Pharmacol. 2025 Apr 15;993:177317. doi: 10.1016/j.ejphar.2025.177317. Epub 2025 Jan 30.
3
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
4
Etanercept and efalizumab for the treatment of psoriasis: a systematic review.依那西普和依法利珠单抗治疗银屑病:一项系统评价。
Health Technol Assess. 2006 Nov;10(46):1-233, i-iv. doi: 10.3310/hta10460.
5
Reversal of morphine-induced respiratory depression with the µ-opioid receptor antagonist naloxonazine engenders excitation and instability of breathing.用μ阿片受体拮抗剂纳洛嗪逆转吗啡引起的呼吸抑制会导致呼吸兴奋和不稳定。
Am J Physiol Lung Cell Mol Physiol. 2025 Jul 1;329(1):L97-L111. doi: 10.1152/ajplung.00045.2025. Epub 2025 May 14.
6
Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission.用于减少恶性疟原虫传播的伯氨喹或其他8-氨基喹啉类药物。
Cochrane Database Syst Rev. 2018 Feb 2;2(2):CD008152. doi: 10.1002/14651858.CD008152.pub5.
7
Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults.成人围手术期持续静脉输注利多卡因用于术后疼痛及恢复
Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD009642. doi: 10.1002/14651858.CD009642.pub3.
8
First-in-Human Study of F-Labeled PET Tracer for Glutamate AMPA Receptor [F]K-40: A Derivative of [C]K-2.用于谷氨酸AMPA受体的F标记PET示踪剂[F]K-40的首次人体研究:[C]K-2的衍生物
J Nucl Med. 2025 Jun 2;66(6):932-939. doi: 10.2967/jnumed.124.269405.
9
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.用于癌症患者和接受姑息治疗患者的阿片类药物引起的肠道功能障碍的μ-阿片受体拮抗剂。
Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3.
10
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.

引用本文的文献

1
AMPA Receptor Modulation in the Treatment of High-Grade Glioma: Translating Good Science into Better Outcomes.AMPA受体调节在高级别胶质瘤治疗中的应用:将优秀科学转化为更好的治疗结果
Pharmaceuticals (Basel). 2025 Mar 8;18(3):384. doi: 10.3390/ph18030384.
2
Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke.CX1837的临床前药理学研究,一种具有更高安全边际的高效安帕金:对治疗阿尔茨海默病和缺血性中风的意义。
Curr Alzheimer Res. 2024;21(10):745-754. doi: 10.2174/0115672050365821250127055828.

本文引用的文献

1
Pattern sensitivity of ampakine-hypoxia interactions for evoking phrenic motor facilitation in anesthetized rat.在麻醉大鼠中,ampakine-缺氧相互作用引起膈神经运动易化的模式敏感性。
J Neurophysiol. 2024 Feb 1;131(2):216-224. doi: 10.1152/jn.00315.2023. Epub 2023 Dec 20.
2
Ampakines Stimulate Diaphragm Activity after Spinal Cord Injury.ampakines 可刺激脊髓损伤后的膈肌活动。
J Neurotrauma. 2021 Dec;38(24):3467-3482. doi: 10.1089/neu.2021.0301.
3
Spinally delivered ampakine CX717 increases phrenic motor output in adult rats.鞘内给予ampakine CX717 可增加成年大鼠膈神经运动输出。
Respir Physiol Neurobiol. 2022 Feb;296:103814. doi: 10.1016/j.resp.2021.103814. Epub 2021 Nov 11.
4
Ampakine pretreatment enables a single hypoxic episode to produce phrenic motor facilitation with no added benefit of additional episodes.阿朴卡林预处理使单次缺氧发作产生膈神经运动易化,而没有额外发作的额外益处。
J Neurophysiol. 2021 Oct 1;126(4):1420-1429. doi: 10.1152/jn.00307.2021. Epub 2021 Sep 8.
5
The impact and mechanism of ampakine CX1739 on protection against respiratory depression in rats.氨苯酮 CX1739 对大鼠呼吸抑制保护作用的影响及其机制。
Future Med Chem. 2020 Dec;12(23):2093-2104. doi: 10.4155/fmc-2020-0256. Epub 2020 Oct 8.
6
Ampakines stimulate phrenic motor output after cervical spinal cord injury.ampakines 可刺激颈脊髓损伤后的膈神经运动输出。
Exp Neurol. 2020 Dec;334:113465. doi: 10.1016/j.expneurol.2020.113465. Epub 2020 Sep 17.
7
Antidepressant-Like Effects of CX717, a Positive Allosteric Modulator of AMPA Receptors.AMPA 受体正变构调节剂 CX717 的抗抑郁样作用。
Mol Neurobiol. 2020 Aug;57(8):3498-3507. doi: 10.1007/s12035-020-01954-x. Epub 2020 Jun 13.
8
Ampakine pretreatment enables a single brief hypoxic episode to evoke phrenic motor facilitation.安贝卡丁预处理使单次短暂缺氧发作能引发膈神经运动易化。
J Neurophysiol. 2020 Mar 1;123(3):993-1003. doi: 10.1152/jn.00708.2019. Epub 2020 Jan 15.
9
Preclinical characterization of AMPA receptor potentiator TAK-137 as a therapeutic drug for schizophrenia.AMPA 受体增强剂 TAK-137 治疗精神分裂症的临床前特征。
Pharmacol Res Perspect. 2019 May 9;7(3):e00479. doi: 10.1002/prp2.479. eCollection 2019 Jun.
10
The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents.新型变构AMPA受体调节剂LCX001对啮齿动物呼吸抑制的保护作用及机制
Front Pharmacol. 2019 Feb 19;10:105. doi: 10.3389/fphar.2019.00105. eCollection 2019.